Lindbrook Capital, LLC Beyond Spring Inc. Transaction History

Lindbrook Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$1.13 - $2.66 $1,029 - $2,423	-911 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$1.68 - $5.01 $325 - $971	194 Added 27.06%	911 $2,000
Q4 2021 Jan 18, 2022	SELL	$4.02 - $16.84 $345 - $1,448	-86 Reduced 10.71%	717 $3,000
Q3 2021 Nov 05, 2021	BUY	$9.26 - $31.31 $5,222 - $17,658	564 Added 235.98%	803 $13,000
Q2 2021 Jul 27, 2021	BUY	$9.37 - $12.12 $2,239 - $2,896	239 New	239 $2,000

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $95.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.